The landscape of clinical trials is evolving to include hybrid and decentralized methods, increasing logistical complexity. By 2024, 50% of trials are expected to use these methods. While remote access enhances convenience, reduces costs, and broadens diversity, it also introduces challenges in remote monitoring and efficiency. 

Decentralized trials offer patient-centric benefits but face issues in maintaining engagement and managing logistics. Apple's ResearchKit saw high initial recruitment but significant dropouts due to logistical oversights. Poor logistics management can lead to errors, higher costs, and adverse outcomes. Integrating data from multiple sources can cause confusion and inaccuracies. Without centralized management, manual errors and missing data are risks. Implementing Interactive Response Technology (IRT) can address these challenges by automating supply management, improving efficiency, and reducing costs. 

IRT supports predictive supply management, risk-based monitoring, and data integration, benefiting patients, researchers, and sponsors. Embracing IRT optimizes clinical trial operations, enhancing patient satisfaction, researcher efficiency, and sponsor results.

Author:

Kevin Landells
Vice President, Delivery, Patient Technology